Skip to main content
. 2005 Jul;187(13):4392–4400. doi: 10.1128/JB.187.13.4392-4400.2005

TABLE 2.

Synthetic oligonucleotides used for targeted deletion or disruption and confirmation of insertion

Target Gene IDa Type of inactivation Oligonucleotide and sequence (5′ to 3′)b
comGB 1029176 Disruption FP042, AACAGCTTATTATGCGCGTGAATG
FP043, AAAGTGTTCCCATGTTTCCTCAGC
comX 1029188 Disruption FP044, GTGAAGATTGGCAACAAGAGG
FP045, TCACATGTTCCATTCTTTCCC
comE 1029114 Disruption FP053, GACGTCTTGAAACCACCATTGCA
FP054, TGCCGTAGAATTCAATCCGTTCA
comC 1029111 Deletion FP009, TATGGACCAAGAAATGCTGT
FP010, AGG/CGCGCCGATAATCTCTAATTCATCAGTCTT
FP011, AGGCCGG/CCAGAAGTTTTACACAAGCTTTG
FP012, TGGAGTTGCTTGATTTCATT
comD 1029115 Deletion FP053, GACGTCTTGAAACCACCATTGCA
FP013, AGG/CGCGCCCGTAACAGCAATCATTATCAGAAA
FP014, AGGCCGG/CCAATCGCGGTATTGGTTTAGCA
FP012, TGGAGTTGCTTGATTTCATT
Kan cassette FP001, AGG/CGCGCCGTTTGATTTTTAATG
FP002, AGGCCGG/CCATCGATACAAATTCCTC
FP037, TCATTTTCTCCCACCAGCTT; confirm insertion
FP038, GCGCCTACGAGGAATTTGTA; confirm insertion
pSF151 FP039, AGCGGATAACAATTTCACACAGGA; confirm insertion
a

S. mutans UA159 gene identification number (ID).

b

Restriction sites are in boldface: AscI, GG/CGCGCC; and FseI, GGCCGG/CC.